Abstract
Purpose
To evaluate the effect of a preexisting glaucoma on the early postoperative outcome of a descemet membrane endothelial keratoplasty (DMEK).
Methods
All patients who underwent DMEK surgery at the Department of Ophthalmology of the University of Muenster with a follow-up of at least 3 months (90d) were included in this study. The best corrected distance visual acuity (BCDVA), the intraocular pressure (IOD), the rate of re-keratoplasty and the rebubbling rate were inter alia recorded. The results of patients with (group 1) and without a preexisting glaucoma (group 2) were compared.
Results
74 eyes of 59 patients with a mean follow-up of 152 ± 70 days were included. 65 eyes were in group 1 and 9 eyes in group 2. The BCDVA significantly improved in both groups after surgery (p < 0.03). The Re-keratoplasty rate (p = 0.172), the number of rebubblings per patient (p = 0.571) and the rebubbling rate (p = 0.939) were not significantly different in patients without glaucoma compared to patients with a preexisting glaucoma.
Conclusions
In the early stage outcome of DMEK no significant impact of a preexisting glaucoma was found.
Similar content being viewed by others
References
Nanavaty M, Wang X, Shortt A (2014) Endothelial keratoplasty versus penetrating keratoplasty for Fuchs endothelial dystrophy. Cochrane Database Syst Rev 14(2). doi:10.1002/14651858.CD008420.pub3
Melles GR, Eggink FA, Lander F, Pels E, Rietveld FJ, Beekhuis WH, Binder PS (1998) A surgical technique for posterior lamellar keratoplasty. Cornea 17(6):618–626
Tappin M (2007) A method for true endothelial cell (Tencell) transplantation using a custommade cannula for the treatment of endothelial cell failure. Eye 21(6):775–779
Melles G, Ong T, Ververs B, van der Wees J (2006) Descemet membrane endothelial keratoplasty (DMEK). Cornea 25(8):987–990
Lions Hornhautbank Baden-Württemberg (2015) 11. Jahresbericht 2014 der Lions Hornhautbank Baden-Württemberg. https://www.uniklinik-freiburg.de/fileadmin/mediapool/07_kliniken/augen/HHB/JahresberichtHHB2014.pdf. Accessed 01 Feb 2016
Eye Bank Association of America (2015) 2014 eye banking statistical report. http://restoresight.org/wp-content/uploads/2015/03/2014_Statistical_Report-FINAL.pdf. Accessed 01 Feb 2016
Spaniol K, Borrelli M, Holtmann C, Schrader S, Geerling G (2015) Complications of Descemet's membrane endothelial keratoplasty. Ophthalmologe 112(12):974–981
Maier A, Wolf T, Gundlach E, Klamann M, Gonnermann J, Bertelmann E, Joussen A, Torun N (2014) Intraocular pressure elevation and post-DMEK glaucoma following Descemet membrane endothelial keratoplasty. Graefes Arch Clin Exp Ophthalmol 252(12):1947–1954. doi:10.1159/000365252
Heinzelmann S, Maier P, Böhringer D, Hüther S, Eberwein P, Reinhard T (2015) Cystoid macular oedema following Descemet membrane endothelial keratoplasty. Br J Ophthalmol 99(1):98–102
Ang M, Wilkins M, Mehta J, Tan D (2016) Descemet membrane endothelial keratoplasty. Br J Ophthalmol 100(1):15–21
Monnereau C, Quilendrino R, Dapena I, Liarakos V, Alfonso J (2014) Multicenter study of Descemet membrane endothelial Keratoplasty. First case series of 18 surgeons. JAMA Ophthalmol 132(10):1192–1198
Quigley H, Broman A (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90(3):262–267
Gipson I (2013) Age-related changes and diseases of the ocular surface and cornea. Invest Ophthalmol Vis Sci 54(14):ORSF48-53
Nguyen P, Khashabi S, Chopra V, Francis B, Heur M, Song J, Yiu S (2013) Descemet stripping with automated endothelial keratoplasty: a comparative study of outcome in patients with preexisting glaucoma. Saudi J Ophthalmol 27(2):73–78
Ward MS, Goins KM, Greiner MA, Kitzmann AS, Sutphin JE, Alward WLM, Greenlee EC, Kwon YH, Zimmerman MB, Wagoner MD (2014) Graft survival versus glaucoma treatment after penetrating or Descemet stripping automated endothelial Keratoplasty. Cornea 33(8):785–789
Anshu A, Price M, Price F (2012) Descemet’s stripping endothelial Keratoplasty: long-term graft survival and risk factors for failure in eyes with preexisting glaucoma. Ophthalmology 119(10):1982–1987
Deutsche Ophthalmologische Gesellschaft, Retinologischen Gesellschaft, Berufsverbandes der Augenärzte Deutschlands (2012) Stellungnahme der Deutschen Ophthalmologischen Gesellschaft, der Retinologischen Gesellschaft und des Berufsverbandes der Augenärzte Deutschlands zur Therapie des Makulaödems beim retinalen Venenverschluss: Therapeutische Strategien. Ophthalmologe 109(8):818–831
Wirtitsch M, Findl O, Heinzl H, Drexler W (2007) Effect of Dorzolamide hydrochloride on central corneal thickness in humans with cornea Guttata. Arch Ophthalmol 125(10):1345–1350
Kwon J, Heo JH, Kim HM, Song JS (2015) Comparison of cytotoxic effects on rabbit corneal endothelium between preservative-free and preservative-containing Dorzolamide/timolol. Korean journal of ophthalmology : Korean J Ophthalmol 29(5):344–350
Srinivas S, Ong A, Zhai C, Bonanno J (2002) Inhibition of carbonic anhydrase activity in cultured bovine corneal endothelial cells by Dorzolamide. Invest Ophthalmol Vis Sci 43(10):3273–3278
Iverson S, Spierer O, Papachristou G, Feuer W, Shi W, Greenfield D, O'Brien T (2015) Comparison of primary graft survival following penetrating keratoplasty and Descemet's stripping endothelial keratoplasty in eyes with prior trabeculectomy. Br J Ophthalmol 99(11):1477–1482
Droutsas K, Lazaridis A, Papaconstantinou D, Brouzas D, Moschos M, Schulze S, Sekundo W (2016) Visual outcomes after Descemet membrane endothelial Keratoplasty versus Descemet stripping automated endothelial Keratoplasty-Comparison of specific matched pairs. Cornea 35(6):765–771
Heinzelmann S, Bohringer D, Eberwein P, Reinhard T, Maier P (2016) Outcomes of Descemet membrane endothelial keratoplasty, Descemet stripping automated endothelial keratoplasty and penetrating keratoplasty from a single centre study. Graefes Arch Clin Exp Ophthalmol 254(3):515–522
Guerra FP, Anshu A, Price MO, Giebel AW, Price FW (2011) Descemet's membrane endothelial keratoplasty: prospective study of 1-year visual outcomes, graft survival, and endothelial cell loss. Ophthalmology 118(12):2368–2373
Rodríguez-Calvo-de-Mora M, Quilendrino R, Ham L, Liarakos V, van Dijk K, Baydoun L, Dapena I, Oellerich S, GR M (2015) Clinical outcome of 500 consecutive cases undergoing Descemet's membrane endothelial Keratoplasty. Ophthalmology 122(3):464–470
Pillar S, Tessler G, Dreznik A, Bor E, Kaiserman I, Bahar I (2013) First 100: learning curve for Descemet stripping automated endothelial keratoplasty. Eur J Opthalmol 23(6):865–869
Satué M, Rodríguez-Calvo-de-Mora M, Naveiras M, Cabrerizo J, Dapena I, Melles G (2015) Standardization of the Descemet membrane endothelial keratoplasty technique: outcomes of the first 450 consecutive cases. Arch Soc Esp Oftalmol 90(8):356–364
Green M, Wilkins M (2015) Comparison of early surgical experience and visual outcomes of DSAEK and DMEK. Cornea 34(11):1341–1344
Reid R, Craig E, Suleman H (2015) Descemet's membrane endothelial keratoplasty (DMEK): first UK prospective study of 1-year visual outcomes, graft survival and endothelial cell count. Br J Ophthalmol 99(2):166–169
Turnbull AM, Tsatsos M, Hossain PN, Anderson DF (2016) Determinants of visual quality after endothelial keratoplasty. Surv Ophthalmol 61(3):257–271
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
No funding was received for this research.
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Financial disclosure
M Treder, Allergan, Novartis; M Alnawaiseh, None; N Eter, Novartis, Bayer, Allergan, Heidelberg Engineering, Bausch and Lomb, Alimera, Roche.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
For this type of study formal consent is not required.
Rights and permissions
About this article
Cite this article
Treder, M., Alnawaiseh, M. & Eter, N. Descemet membrane endothelial keratoplasty (DMEK) early stage graft failure in eyes with preexisting glaucoma. Graefes Arch Clin Exp Ophthalmol 255, 1417–1421 (2017). https://doi.org/10.1007/s00417-017-3668-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-017-3668-z